Top Industry Leaders in the Asia Pacific CRO Market
Latest Asia CRO Companies Update
Surging clinical trial activity APAC now accounts for over 50% of global clinical trials, attracting sponsors with its diverse patient populations, favorable regulatory environments, and cost-effective solutions.
WuXi AppTec Acquired US-based Altimmune for $1.7 billion, strengthening its global reach and capabilities in biologics development and manufacturing.
Syneos Health Expanded its APAC footprint by acquiring Australia-based Clinical Research Consulting Services (CRC Services) and Indian CRO Clinigene.
Parexel Partnered with Chinese biotech company CTTQ to establish a joint venture focused on clinical trial execution in China.
List of Asia CRO Key companies in the market
- IQVIA Inc.
- Parexel International Corporation
- Charles River Laboratories, Inc.
- ACM Global Laboratories
- Merck KGaA (Bio Reliance Corporation)
- Celerion
- Clinitude
- Laboratory Corporation of America Holdings (Covance Inc.)
- Novotech
- Icon PLC